초음파 진단 장비 시장 : 세계 시장 예측(2026-2032년)

The Ultrasound Device Market is projected to grow by USD 14.48 billion at a CAGR of 5.42% by 2032.

Ultrasound Device Market Introduction

Ultrasound devices are central to modern diagnostic imaging, image-guided intervention, obstetric care, cardiovascular assessment, emergency medicine, and point-of-care clinical decision-making. Unlike ionizing imaging modalities, ultrasound uses high-frequency sound waves to generate real-time images, supporting broad use across hospitals, ambulatory settings, specialty clinics, rural health programs, and increasingly home-adjacent care models. Demand is being shaped by aging populations, rising chronic disease burden, maternal and fetal monitoring needs, trauma and emergency care requirements, and the global shift toward faster, lower-cost, noninvasive diagnostic workflows. The ultrasound device landscape spans cart-based systems, compact portable platforms, handheld ultrasound, Doppler ultrasound, 2D, 3D, and 4D imaging, as well as specialized probes and software-enabled image interpretation tools. Regulatory expectations around device safety, image quality, cybersecurity, interoperability, and clinical validation are increasing as ultrasound moves closer to frontline care. For healthcare providers, the strategic value of ultrasound lies in its ability to improve diagnostic access, shorten time to treatment, reduce dependence on centralized imaging departments, and support clinical confidence across a wide range of specialties.

Transformative Shifts in the Ultrasound Device Landscape

The ultrasound device landscape is undergoing a structural transformation driven by miniaturization, digital connectivity, advanced transducer engineering, portable imaging adoption, and workflow integration. Point-of-care ultrasound is moving imaging from radiology suites into emergency rooms, intensive care units, primary care clinics, anesthesia departments, sports medicine, and remote health settings. Handheld and laptop-based devices are expanding access where cart-based systems are impractical, especially in rural clinics, ambulances, field hospitals, and low-resource environments. At the same time, hospitals are prioritizing ultrasound platforms that support interoperability with electronic health records, picture archiving and communication systems, and enterprise imaging infrastructure. Clinical users are seeking faster boot times, improved battery life, intuitive interfaces, automated measurements, and standardized imaging protocols to reduce operator variability. In parallel, infection prevention requirements, probe reprocessing standards, and growing awareness of ultrasound training gaps are influencing procurement and implementation decisions. These shifts are redefining ultrasound from a department-based diagnostic tool into a distributed, connected, and clinician-operated imaging ecosystem.

Cumulative Impact of Artificial Intelligence on Ultrasound Devices

Artificial intelligence is reshaping ultrasound devices by addressing one of the modality's most persistent challenges: operator dependence. AI-enabled ultrasound workflows can support image acquisition guidance, anatomical landmark recognition, automated measurements, quality assurance, triage support, lesion characterization, and structured reporting. In obstetrics, cardiology, vascular imaging, musculoskeletal care, and emergency medicine, AI tools are being evaluated and deployed to improve repeatability, reduce scanning time, and assist less experienced operators. Automated ejection fraction assessment, fetal biometric measurements, bladder volume calculations, nerve identification, thyroid nodule assessment, and lung ultrasound interpretation are among the clinical areas where AI is contributing to workflow consistency. The cumulative impact extends beyond image interpretation; AI can help standardize protocols, reduce training barriers, enhance remote supervision, and support tele-ultrasound models in underserved regions. However, adoption depends on rigorous clinical validation, transparent performance monitoring, cybersecurity safeguards, data privacy compliance, integration into existing imaging workflows, and clear accountability for clinician oversight. As AI becomes embedded in ultrasound platforms, successful implementation will require alignment among device design, clinical governance, reimbursement pathways, and continuous education.

Key Regional Insights for Ultrasound Devices

Asia-Pacific is experiencing rapid ultrasound adoption supported by large patient populations, expanding hospital infrastructure, maternal health programs, and growing demand for affordable diagnostic imaging across China, India, Japan, South Korea, Australia, and Southeast Asian economies. Portable and point-of-care ultrasound are particularly relevant in geographically dispersed and rural communities where access to advanced imaging remains uneven, while aging demographics in several Asia-Pacific countries are increasing the need for cardiac, abdominal, vascular, and musculoskeletal ultrasound. North America remains a highly advanced ultrasound environment, driven by widespread use in emergency medicine, cardiology, obstetrics, radiology, anesthesiology, and primary care, with strong emphasis on regulatory-cleared technologies, reimbursement alignment, clinical training, cybersecurity, and interoperability with enterprise health IT systems. Latin America is seeing broader ultrasound utilization in public and private healthcare settings, with Brazil and Mexico acting as important adoption centers; demand is supported by maternal care, abdominal imaging, cardiovascular screening, trauma assessment, and cost-effective alternatives to higher-complexity imaging. Europe is characterized by structured regulatory oversight, strong clinical specialization, and growing adoption of portable ultrasound in emergency, critical care, and outpatient diagnostics, with the European Union's medical device regulatory framework influencing clinical evidence, safety, software lifecycle management, and post-market surveillance expectations. The Middle East is investing in hospital modernization, specialty care, and digital health infrastructure, with ultrasound playing a key role in women's health, cardiology, vascular diagnostics, and acute care settings across Gulf healthcare systems. Africa shows strong need for accessible ultrasound due to maternal health priorities, infectious disease burden, trauma care, and limited radiology infrastructure in many areas; portable and battery-operated systems, tele-ultrasound, durable probes, and workforce training are critical to improving diagnostic reach across the continent.

Key Group Insights for Ultrasound Device Adoption

ASEAN countries are advancing ultrasound access through public health investments, private hospital growth, and increasing use of portable imaging in maternal care, emergency medicine, and rural outreach, although adoption varies according to healthcare financing, workforce availability, procurement capacity, and infrastructure maturity. The GCC is emphasizing premium healthcare infrastructure, specialty hospitals, medical tourism, and digital transformation, making ultrasound important for obstetrics, cardiology, vascular imaging, interventional guidance, and point-of-care applications in advanced acute care environments. The European Union provides a highly regulated and clinically mature environment where ultrasound device adoption is shaped by medical device conformity requirements, evidence-based procurement, data protection rules, health technology assessment practices, and cross-border healthcare quality standards. BRICS economies combine large population needs with expanding domestic healthcare capacity, creating strong relevance for cost-effective, scalable ultrasound platforms in maternal health, chronic disease diagnosis, oncology pathways, emergency care, and community-based screening. G7 countries represent advanced clinical adoption environments with established imaging infrastructure, higher expectations for cybersecurity and interoperability, and increasing focus on AI-enabled workflow efficiency, clinician training, aging population needs, and value-based care delivery. NATO member countries, many of which overlap with advanced European and North American health systems, also prioritize resilient medical infrastructure, deployable care capabilities, emergency preparedness, and field-ready diagnostic imaging, strengthening the role of portable ultrasound in civilian and defense medical readiness.

Key Country Insights for Ultrasound Devices

The United States demonstrates broad ultrasound utilization across hospital, outpatient, emergency, obstetric, cardiovascular, and primary care settings, with adoption influenced by regulatory clearance, clinical guidelines, payer policies, imaging accreditation, and growing use of point-of-care ultrasound training in medical education. Canada emphasizes equitable access, provincial procurement structures, and ultrasound use across urban hospitals and remote communities, where portable imaging can reduce diagnostic travel burdens. Mexico and Brazil are important Latin American markets for ultrasound use in maternal health, abdominal diagnostics, cardiovascular assessment, emergency care, and private-sector imaging services, while public health systems continue to seek scalable and cost-efficient diagnostic solutions. The United Kingdom integrates ultrasound into National Health Service pathways across radiology, maternity, musculoskeletal care, emergency departments, and general practice initiatives, with workforce capacity and waiting time reduction remaining important priorities. Germany, France, Italy, and Spain maintain strong clinical use of ultrasound across specialty care, supported by established hospital infrastructure, physician training, and European regulatory compliance requirements; Germany is notable for broad physician-led ultrasound use, while France, Italy, and Spain continue to expand applications in outpatient, maternity, chronic disease, and acute care pathways. Russia relies on ultrasound across general diagnostics, obstetrics, cardiology, and regional healthcare facilities, with emphasis on accessible imaging across a wide geography. China is advancing ultrasound adoption through hospital expansion, domestic technology development, AI integration, and demand across tertiary and primary care systems. India shows high relevance for portable and affordable ultrasound due to maternal health needs, rural access gaps, emergency medicine development, and expanding private diagnostic networks, while regulatory controls remain important for ethical prenatal imaging use. Japan has mature ultrasound adoption supported by aging demographics, cardiology, gastroenterology, oncology surveillance, and preventive screening practices, with demand for high-resolution and workflow-efficient platforms. Australia uses ultrasound widely in metropolitan hospitals, regional care, emergency medicine, obstetrics, and remote health services, where telehealth-enabled imaging can support care continuity. South Korea combines advanced hospital infrastructure, strong digital health capabilities, and high clinical uptake in specialty diagnostics, making ultrasound innovation, compact systems, and AI-enabled imaging increasingly relevant.

Actionable Recommendations for Ultrasound Device Industry Leaders

Industry leaders should prioritize clinically validated innovation that improves diagnostic confidence, usability, and workflow efficiency without increasing operational complexity. Product strategies should focus on portable and handheld ultrasound, AI-assisted acquisition and measurement, high-performance probes, durable battery systems, simplified user interfaces, and secure integration with electronic health records and imaging archives. Manufacturers and healthcare providers should invest in structured training programs, credentialing pathways, and competency-based education to support safe point-of-care ultrasound expansion. Procurement teams should evaluate total cost of ownership, probe durability, service support, cybersecurity controls, interoperability, infection prevention requirements, and software update pathways rather than relying only on upfront device cost. For emerging and underserved regions, scalable models should include portable systems, remote mentoring, tele-ultrasound support, multilingual user interfaces, and maintenance networks that can operate in low-resource settings. AI deployment should be governed by transparent validation, bias monitoring, clinician oversight, and regulatory compliance. Stakeholders should also align ultrasound adoption with care pathways where real-time imaging can reduce diagnostic delays, such as maternal care, cardiac assessment, vascular access, trauma evaluation, lung assessment, abdominal pain evaluation, and chronic disease management.

Research Methodology

This executive summary is developed through a structured secondary research approach using publicly available and verifiable sources, including regulatory authority publications, healthcare policy documents, clinical practice guidelines, peer-reviewed medical literature, international health organization resources, medical device safety communications, hospital technology adoption references, and standards related to medical device quality, interoperability, and cybersecurity. The methodology focuses on qualitative assessment of ultrasound device trends, clinical applications, regional adoption drivers, regulatory considerations, technology evolution, and healthcare delivery priorities. Information is cross-checked across multiple credible sources to ensure consistency and relevance, with emphasis on verified developments such as point-of-care ultrasound expansion, AI-enabled workflow support, portability, interoperability, maternal health applications, cardiovascular imaging, emergency care use cases, tele-ultrasound, and infection prevention practices. The analysis intentionally avoids market sizing, market share, revenue estimation, and forecasting, and instead concentrates on evidence-backed strategic insights for decision-makers evaluating the ultrasound device ecosystem.

Conclusion

Ultrasound devices are evolving from conventional imaging systems into connected, portable, intelligent diagnostic platforms that support faster and more accessible care. The strongest growth drivers are clinical and operational rather than speculative: demand for noninvasive imaging, expansion of point-of-care ultrasound, maternal and cardiovascular health needs, emergency medicine adoption, rural diagnostic access, and the push for efficient healthcare delivery. Artificial intelligence, tele-ultrasound, handheld devices, and interoperable imaging workflows are strengthening ultrasound's role across both advanced and resource-constrained healthcare systems. Regional and country-level adoption patterns differ, but the strategic direction is consistent: healthcare systems need ultrasound solutions that are accurate, affordable, easy to use, secure, and clinically validated. Organizations that combine technology innovation with training, workflow integration, regulatory discipline, cybersecurity readiness, and equitable access strategies will be best positioned to support the next phase of ultrasound-enabled care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Ultrasound Device Market, by Product Type

• 7.1. Introduction
• 7.2. 2D Ultrasound
• 7.3. 3D Ultrasound
• 7.4. 4D Ultrasound
• 7.5. Doppler Ultrasound
• 7.6. High-Intensity Focused Ultrasound (HIFU)

8. Ultrasound Device Market, by Component

• 8.1. Introduction
• 8.2. Central Processing Unit
• 8.3. Disk Storage
• 8.4. Display Devices
  • 8.4.1. B/W Ultrasound
  • 8.4.2. Color Ultrasound
• 8.5. Transducer Probes
  • 8.5.1. Linear Array Probes
  • 8.5.2. Phased Array Probes

9. Ultrasound Device Market, by Portability

• 9.1. Introduction
• 9.2. Compact/Handheld
• 9.3. Trolley/Cart-based

10. Ultrasound Device Market, by Application

• 10.1. Introduction
• 10.2. Cardiology
• 10.3. Obstetrics and Gynecology
• 10.4. Ophthalmology
• 10.5. Radiology
• 10.6. Urology

11. Ultrasound Device Market, by End-User

• 11.1. Introduction
• 11.2. Academic & Research Institutions
• 11.3. Ambulatory Care Centers
• 11.4. Diagnostic Imaging Centers
• 11.5. Hospitals & Clinics
• 11.6. Maternity Centers

12. Ultrasound Device Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Ultrasound Device Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Ultrasound Device Market, by Country

• 14.1. United States
• 14.2. China
• 14.3. Germany
• 14.4. United Kingdom
• 14.5. India
• 14.6. Japan
• 14.7. Russia
• 14.8. Brazil
• 14.9. Canada
• 14.10. Italy
• 14.11. Mexico
• 14.12. France
• 14.13. Spain
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. FPNV Positioning Matrix, 2025
• 15.3. Market Concentration Analysis, 2025
  • 15.3.1. Concentration Ratio (CR)
  • 15.3.2. Herfindahl Hirschman Index (HHI)
• 15.4. Recent Developments & Impact Analysis, 2025
• 15.5. Product Portfolio Analysis, 2025
• 15.6. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Advanced Instrumentations Inc.
• 16.2. Alpinion Medical System Corp.
• 16.3. Becton, Dickinson and Company
• 16.4. Butterfly Network Inc.
• 16.5. Canon Medical Systems Corporation
• 16.6. Chison Medical Technologies Co. Ltd.
• 16.7. Clarius Mobile Health Corp.
• 16.8. Draminski S.A.
• 16.9. Edan Instruments Inc.
• 16.10. Esaote SpA
• 16.11. Fujifilm Holdings Corporation
• 16.12. Fukuda Denshi Co., Ltd.
• 16.13. GE HealthCare Technologies Inc.
• 16.14. Healcerion Co., Ltd.
• 16.15. Hitachi Ltd.
• 16.16. Hologic Inc.
• 16.17. Konica Minolta, Inc.
• 16.18. Koninklijke Philips N.V.
• 16.19. Mindray Medical International limited
• 16.20. Narang Medical Limited
• 16.21. Neusoft Corporation
• 16.22. PerkinElmer, Inc.
• 16.23. Samsung Electronics Co. Ltd.
• 16.24. Siemens Healthineers AG
• 16.25. SonoScape Medical Corp.
• 16.26. Teratech Corporation